Our clinicopathologic observation that RET fusion kinase occurs in younger never smoker patients without other known driver alterations is consistent with observations in fusion kinase driven NSCLC and will require further validation in a larger cohort of CRC patients [11, 23]. Here, RET is linked to colorectal carcinoma.